share_log

JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $43

Benzinga ·  Nov 25 22:22  · Ratings

JP Morgan analyst Eric Joseph maintains TG Therapeutics (NASDAQ:TGTX) with a Overweight and raises the price target from $30 to $43.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment